Cardiovascular Research Foundation

Fiscal year ending 2024. Filed on November 14, 2025.

1700 Broadway
New York, New York 10019

Cardiovascular Research Foundation (EIN: 52-1752653) has filed an IRS Form 990 since at least fiscal year 2016. In its fiscal year 2024 IRS Form 990 filing, Cardiovascular Research Foundation, a 501(c)(3) charitable organization, reported compensation for 8 out of 213 total employees. Among the employees shown here, the average compensation is $558,308. The highest compensated employee at Cardiovascular Research Foundation is Juan F Granada, M.D. with fiscal year 2024 compensation of $1,002,558.

Revenue, expenses, and employee compensation

Revenue

$68,904,326

Expenses

$66,655,898

Employee compensation

$26,821,269

Reported Compensated Employees

Juan F Granada, M.D.

Chief Executive Officer and Director

$1,002,558

$933,460 No related comp$69,098

David Cohen

Director of Clinical and OUT

$736,673

$700,158 No related comp$36,515

Eileen Morales

Chief Financial Officer

$513,647

$474,963 No related comp$38,684

Donald L Abrams

Chief Legal Officer

$510,258

$482,912 No related comp$27,346

Alexandra Popma

Director

$484,897

$461,897 No related comp$23,000

Tricia Rawh

Executive Director, CED

$454,492

$431,480 No related comp$23,012

Grzegorz Kaluza

Research Director

$392,202

$325,318 No related comp$66,884

Daniel Burkoff

Director of Heart Failure

$371,740

$315,075 No related comp$56,665

Non-Employee Board Members

Jeffrey W Moses, M.D.

William A Himmelsbach

Director

Contractors

Gary S Mintz MD LLC

Management Consulting

$310,000

Lissom Corp.

Management Consulting

$201,093

Fixed Gear Designs

Management Consulting

$179,393

Very Fine Work

Management Consulting

$155,870

Mattthew Schwartz Design Studio LLC

Management Consulting

$140,000

Mission Statement

CARDIOVASCULAR RESEARCH FOUNDATION IS AN INDEPENDENT, ACADEMICALLY FOCUSED ORGANIZATION DEDICATED TO IMPROVING THE SURVIVAL AND QUALITY OF LIFE FOR PEOPLE WITH CARDIOVASCULAR DISEASE THROUGH RESEARCH AND EDUCATION. THE ORGANIZATION HAS PLAYED A MAJOR ROLE IN REALIZING DRAMATIC IMPROVEMENTS IN THE LIVES OF COUNTLESS NUMBERS OF PATIENTS BY ESTABLISHING THE SAFE USE OF NEW TECHNOLOGIES AND THERAPIES IN THE SUBSPECIALTY OF INTERVENTIONAL CARDIOLOGY AND ENDOVASCULAR MEDICINE.